Form D · Biotechnology
Fibrocell Science, Inc.
Exton, PA · CIK 0000357097
Offering snapshot reported Dec 20, 2018 · SEC filing
- Reported sold
- $900K Offering amount: $900K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2018 | Initial | $900,000 | No comparison | 2 | SEC filing |
| Jul 17, 2018 | Initial | $3,064,216 | No comparison | 3 | SEC filing |
| Jun 13, 2018 | Initial | $5,087,980 | No comparison | 4 | SEC filing |
| Aug 24, 2016 | Initial | $17,625,000 | No comparison | 14 | SEC filing |
| Oct 15, 2012 | Initial | $45,000,000 | No comparison | 114 | SEC filing |
| May 18, 2012 | Initial | $3,353,000 | No comparison | 63 | SEC filing |
| Aug 18, 2011 | Initial | $22,800,000 | No comparison | 75 | SEC filing |
| Feb 3, 2011 | Initial | $4,293,000 | No comparison | 67 | SEC filing |
| Aug 4, 2010 | Initial | $2,702,000 | No comparison | 20 | SEC filing |
| Mar 29, 2010 | Initial | $3,807,500 | No comparison | 23 | SEC filing |
| Mar 29, 2010 | Initial | $4,880,093 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-328564
Source: Form D, filed Dec 20, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean D. Buckley | Executive |
| Declan Daly | Director, Executive |
| Keith A. Goldan | Executive |
| Paul Hopper | Director |
| Julian P. Kirk | Director |
| George J. Korkos | Director |
| Robert Langer | Director |
| Robert Langor | Director |
| Michael F. Marino | Executive |
| John M. Maslowski | Director, Executive |
| Marc B. Mazur | Director |
| Kelvin D. Moore | Director |
| David Pernock | Director, Executive |
| Marcus E. Smith | Director |
| Christine St.Clare | Director |
| Douglas J. Swirsky | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
405 Eagleview Boulevard
Exton, PA, 19341
Exton, PA, 19341